GET DAILY SIGNALSProcter & Gamble (PG) Delivers +4% Sales Growth and Beats Estimates
Key Takeaways
- Net sales rose 4% year over year to $23.28 billion, beating the roughly $22.8 billion consensus estimate.
- Core (adjusted) earnings per share of $2.00 topped the $1.88 analyst estimate and grew 1% from the prior year.
- Organic sales increased 4%, with every product category growing and volume up 2.4%.
- Core gross margin fell 150 basis points to 50%, pressured by higher commodity costs.
- P&G raised its all-in sales growth outlook to 2%–4% while keeping its core EPS guidance of $6.89 to $7.11.
Why These Results Matter
Procter & Gamble, the consumer goods giant behind brands such as Tide, Pampers, Gillette, and Pantene, delivered its fiscal first-quarter 2027 results on October 22, 2026, for the three months ended September 30, 2026. The report matters because PG is widely viewed as a bellwether for consumer staples and household spending. After a stretch of weak volume as shoppers traded down, investors were watching closely for signs of a demand recovery. The quarter showed broad-based top-line momentum, but also a familiar challenge: rising input costs squeezing margins. The results, and the company's updated outlook, help clarify whether PG can sustain growth while protecting profitability.
The Numbers Behind the Beat
PG reported net sales of $23.28 billion, up 4% from $22.39 billion a year earlier and ahead of the roughly $22.8 billion analysts expected. Organic sales, which strip out currency moves and acquisitions and divestitures, rose 4%, driven by volume growth of 2.4%—a notable rebound after fiscal 2026 produced just one quarter of volume growth.
On the bottom line, net earnings attributable to Procter & Gamble were $4.73 billion, or $1.97 per share under generally accepted accounting principles (GAAP), down slightly from $4.75 billion, or $1.95 per share, a year ago. Core earnings per share (EPS), which exclude restructuring and other one-time items, came in at $2.00, up 1% and above the $1.88 consensus.
Growth was broad-based. Beauty led with organic sales up 5.4%, followed by Fabric & Home Care (up 4.8%) and Grooming (up 4.5%), while Baby, Feminine & Family Care and Health Care grew 3% and 2.7%, respectively. However, profitability was under pressure: core gross margin declined 150 basis points to 50%, and core operating margin slipped 80 basis points to 25.9%, reflecting higher commodity and transportation costs.
For the full fiscal year, PG raised its all-in sales growth outlook to 2%–4% from 1%–3%, citing its completed $3.8 billion acquisition of health-and-wellness brand Thorne on October 1, 2026. The company reiterated organic sales growth of 1%–3% and core EPS of $6.89 to $7.11.
Market Reaction and Investor Sentiment
Investors responded positively to the results. PG shares rose more than 5% in early trading on October 22, putting the stock on track for its largest single-day gain since March 2020. The rally reflected relief that volume growth had returned across categories and that the company topped estimates on both sales and earnings, even as it flagged rising input costs. Sentiment was further supported by the upgraded all-in sales guidance and management's comments that the strong start keeps PG on track to hit its full-year ranges. Still, analysts noted the competitive environment remains "intense" and that a bifurcated consumer—higher-income shoppers trading up while lower-income households seek value—continues to shape demand.
Forward Outlook and Key Factors to Monitor
The biggest near-term watch item is cost inflation. PG expects a roughly $1.4 billion after-tax headwind from commodity, energy, and transportation costs in fiscal 2027, and management said it plans to offset part of that through productivity savings and innovation-led pricing rather than blunt price increases.
Investors should also track whether the volume rebound is sustainable. PG reported volume growth of 2.4% this quarter after largely flat or negative volume trends in fiscal 2026. Continued share gains among top U.S. retailers—where more than 70% of its largest customers are now holding or growing share—will be a key signal of that durability.
Finally, the integration of Thorne, which closed on October 1, 2026, will shape the sales outlook and may open new growth avenues in health and wellness. Margin progression, free cash flow productivity, and the company's ability to maintain its $6.89 to $7.11 core EPS guidance while navigating currency swings and geopolitical uncertainty round out the factors worth monitoring in the quarters ahead.
Refining Analysis with AI Tools
One thing that stands out when reviewing earnings like these is how useful it can be to cross-check patterns across peers. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry. It helps surface similar opportunities efficiently when evaluating fundamentals and technical signals side by side.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PG's RSI Oscillator peaks and leaves overbought zone
The 10-day RSI Indicator for PG moved out of overbought territory on November 11, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 instances where the indicator moved out of the overbought zone. In 14 of the 29 cases the stock moved lower in the days that followed. This puts the odds of a move down at 48%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
PG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PG just turned positive on October 07, 2026. Looking at past instances where PG's MACD turned positive, the stock continued to rise in 21 of 46 cases over the following month. The odds of a continued upward trend are 46%.
The 50-day moving average for PG moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where PG advanced for three days, in 156 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
The Aroon Indicator entered an Uptrend today. In 87 of 254 cases where PG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 34%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 20 (best 1 - 100 worst), indicating outstanding price growth. PG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.204) is normal, around the industry mean (21.731). P/E Ratio (24.504) is within average values for comparable stocks, (16.288). PG's Projected Growth (PEG Ratio) (3.813) is slightly higher than the industry average of (1.518). Dividend Yield (0.026) settles around the average of (0.032) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (1.902).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of branded consumer packaged goods
Industry HouseholdPersonalCare
Advertisement